Body adipose tissue depots and treatment outcomes for women with breast cancer: A systematic review
CONCLUSION: This systematic review found an association between increased VAT and SAT with worse outcomes in patients with BC. However, due to the heterogeneity of the included studies, further research with homogeneous methodologies is necessary to better understand the impact of body adipose tissue depots on treatment outcomes. Such knowledge could lead to improved care for this patient population.PMID:38547637 | DOI:10.1016/j.clnu.2024.03.010 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - March 28, 2024 Category: Cancer & Oncology Authors: Taiara Scopel Poltronieri Raquel Stocker P érsico Luciana Ver çoza Viana Source Type: research
Quality of Life Outcomes Associated With Optimization of Treatment by Omitting Radiotherapy in Early Breast Cancer
CONCLUSIONS: Omission of RT was associated with better QoL and functional and cosmetic outcomes. It was highly acceptable to patients. Clinicians should consider the potential for preserved QoL associated with treatment optimization via omission of RT in treatment planning for patients with EBC.PMID:38548516 | DOI:10.1016/j.clbc.2024.03.002 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - March 28, 2024 Category: Cancer & Oncology Authors: Lesley Stafford Michelle Sinclair Phyllis Butow Janemary Hughes Allan Park Leslie Gilham Allison Rose G Bruce Mann Source Type: research
Photoacoustic Imaging Radiomics to Identify Breast Cancer in BI-RADS 4 or 5 Lesions
CONCLUSIONS: The nomogram developed with BI-RADS and PAI radiomics score can effectively identify BC in BI-RADS 4 or 5 lesions. This technique has the potential to further improve early diagnostic accuracy for BC.PMID:38548517 | DOI:10.1016/j.clbc.2024.02.017 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - March 28, 2024 Category: Cancer & Oncology Authors: Guoqiu Li Zhibin Huang Hui Luo Hongtian Tian Zhimin Ding Yaohong Deng Jinfeng Xu Huaiyu Wu Fajin Dong Source Type: research
(18)F-FES PET/CT for Post-Cryoablation Evaluation of Breast Cancer
Clin Breast Cancer. 2024 Feb 28:S1526-8209(24)00043-0. doi: 10.1016/j.clbc.2024.02.005. Online ahead of print.NO ABSTRACTPMID:38548518 | DOI:10.1016/j.clbc.2024.02.005 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - March 28, 2024 Category: Cancer & Oncology Authors: Celina Duran Robert C Ward Elizabeth H Dibble Source Type: research
Exploring the Oncogenic Potential of TIMM8A: A Crucial Factor in Breast Cancer Tumorigenesis
CONCLUSION: This study revealed that TIMM8A is an oncogene and is critical for the tumorigenesis of breast carcinoma.PMID:38548519 | DOI:10.1016/j.clbc.2024.02.011 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - March 28, 2024 Category: Cancer & Oncology Authors: Yili Chi Suzita Hirachan Yuying Zhou Adheesh Bhandari Source Type: research
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022
CONCLUSION: G-CSF may be beneficial as primary prophylaxis during CBZ administration for metastatic castration resistant prostate cancer, and we made a "weak recommendation to perform" with an annotation of the relevant regimen.PMID:38538963 | DOI:10.1007/s10147-024-02501-7 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - March 28, 2024 Category: Cancer & Oncology Authors: Shoji Kimura Keisuke Shigeta Shingo Tamura Keita Uchino Takahiro Kimura Yukinori Ozaki Hiroshi Nishio Kenji Tsuchihashi Eiki Ichihara Makoto Endo Shingo Yano Dai Maruyama Tetsuhiro Yoshinami Nobuyuki Susumu Munetaka Takekuma Takashi Motohashi Mamoru Ito E Source Type: research
Real-world experience with pertuzumab and trastuzumab combined with chemotherapy in neoadjuvant treatment for patients with early-stage HER2-positive breast cancer: the NEOPERSUR study
CONCLUSION: Neoadjuvant pertuzumab and trastuzumab plus CT achieve high pCR rates in real-life patients with HER2-positive early BC, showing an acceptable safety profile. Innovative adjuvant strategies are essential in patients at high risk of distant disease recurrence.PMID:38538968 | DOI:10.1007/s12094-024-03440-5 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - March 28, 2024 Category: Cancer & Oncology Authors: Alejandro Falc ón González Josefina Cruz Jurado Elisenda Llabr és Valenti Roc ío Urbano Cubero Maria Carmen Álamo de la Gala Mar ía Antonia Martínez Guisado Roc ío Álvarez Ambite Carlos Jos é Rodríguez González Marta Am érigo Góngora Lourdes Source Type: research
The Correlation of Body Mass Index with Risk of Recurrence in Post-Menopausal Women with Breast Cancer Undergoing Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
Conclusions: BMI seems to correlate with an increased rate of recurrence, especially in the breast, and a higher glucose uptake in post-menopausal patients with recurrent breast cancer.PMID:38541801 | DOI:10.3390/jcm13061575 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - March 28, 2024 Category: Cancer & Oncology Authors: Natale Quartuccio Salvatore Ialuna Sabina Pulizzi Dante D'Oppido Mauro Antoni Antonino Maria Moreci Source Type: research
Inflammatory Cytokines Associated with Obesity, Type-2 Diabetes, and Hypertension Exacerbate Breast Cancer Risk in Underserved African American and Latin American Women
Conclusions: Comorbidity-associate cytokines could augment the risk of breast cancer for AA and LA women.PMID:38541912 | DOI:10.3390/jcm13061687 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - March 28, 2024 Category: Cancer & Oncology Authors: Yanyuan Wu Eduard Karapetyan Pranabananda Dutta Magda Shaheen Jaydutt V Vadgama Source Type: research
Early Breast Cancer: Could Combined LOCalizer(TM) and Ultrasound Localization Replace the Metallic Wire? A Multicentric Study
Conclusions: In the current study, LOCalizerTM associated with US could be considered an excellent approach for localizing non-palpable BC. Further larger comparative studies are needed to address this issue.PMID:38541938 | DOI:10.3390/jcm13061713 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - March 28, 2024 Category: Cancer & Oncology Authors: Simona Parisi Claudio Gambardella Antonio Santoriello Roberto Ruggiero Francesco Iovino Francesca Fisone Federico Maria Mongardini Francesco Saverio Lucido Salvatore Tolone Ludovico Docimo Source Type: research
Aromatase Inhibitors and Plasma Lipid Changes in Postmenopausal Women with Breast Cancer: A Systematic Review and Meta-Analysis
Conclusions: Our results suggest that, despite statistically significant results, EXE and LET may not be sufficient to cause severe dyslipidemia in patients without cardiovascular comorbidities according to the AHA/ACC Guideline on the Management of Blood Cholesterol. However, the results may raise the question of monitoring the effects of AIs in patients, especially those with pre-existing cardiovascular risk factors such as dyslipidemia.PMID:38542042 | DOI:10.3390/jcm13061818 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - March 28, 2024 Category: Cancer & Oncology Authors: B álint Bérczi Nelli Farkas P éter Hegyi Barbara T óth Dezs ő Csupor Bal ázs Németh Anita Luk ács L ászló Márk Czumbel Be áta Kerémi Istv án Kiss Andrea Szab ó G ábor Varga G ábor Gerber Zolt án Gyöngyi Source Type: research
Decision regret of cancer patients after radiotherapy: results from a cross-sectional observational study at a large tertiary cancer center in Germany
CONCLUSIONS: The German version of the DRS could be used to assess decision regret in a diverse cohort of cancer patients undergoing radiotherapy. Decision regret was prevalent in a considerable proportion of patients. Further studies are necessary to validate these findings and obtain causal factors associated with decision regret after radiotherapy.PMID:38546873 | DOI:10.1007/s00432-024-05638-0 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - March 28, 2024 Category: Cancer & Oncology Authors: Alexander R ühle Leonie Wieland Andreas Hinz Anja Mehnert-Theuerkauf Nils H Nicolay Clemens Seidel Source Type: research
Correction: Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis
J Cancer Res Clin Oncol. 2024 Mar 28;150(3):166. doi: 10.1007/s00432-024-05636-2.NO ABSTRACTPMID:38546886 | DOI:10.1007/s00432-024-05636-2 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - March 28, 2024 Category: Cancer & Oncology Authors: Chenlu Wu Jiafei Ying Mei Dai Jing Peng Danhua Zhang Source Type: research
Body adipose tissue depots and treatment outcomes for women with breast cancer: A systematic review
CONCLUSION: This systematic review found an association between increased VAT and SAT with worse outcomes in patients with BC. However, due to the heterogeneity of the included studies, further research with homogeneous methodologies is necessary to better understand the impact of body adipose tissue depots on treatment outcomes. Such knowledge could lead to improved care for this patient population.PMID:38547637 | DOI:10.1016/j.clnu.2024.03.010 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - March 28, 2024 Category: Cancer & Oncology Authors: Taiara Scopel Poltronieri Raquel Stocker P érsico Luciana Ver çoza Viana Source Type: research
Quality of Life Outcomes Associated With Optimization of Treatment by Omitting Radiotherapy in Early Breast Cancer
CONCLUSIONS: Omission of RT was associated with better QoL and functional and cosmetic outcomes. It was highly acceptable to patients. Clinicians should consider the potential for preserved QoL associated with treatment optimization via omission of RT in treatment planning for patients with EBC.PMID:38548516 | DOI:10.1016/j.clbc.2024.03.002 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - March 28, 2024 Category: Cancer & Oncology Authors: Lesley Stafford Michelle Sinclair Phyllis Butow Janemary Hughes Allan Park Leslie Gilham Allison Rose G Bruce Mann Source Type: research
